[1] 王梅. 核苷类似物抗病毒治疗HBeAg(-)/(+)患者肝癌发生的临床观察[J].中国农村卫生,2017,21(4):26.
[2] 蒋蒙,刘亚允,孙双双,等.核苷(酸)类似物抗病毒治疗慢性乙型肝炎患者发生原发性肝癌的危险因素分析[J].肝脏,2018,23(10):864-867.
[3] 赵龙凤,王艳.临床一线抗病毒药物对慢性乙型肝炎治疗结局的影响[J].中华肝脏病杂志,2017,25(7):485-489.
[4] 杨燕卿,储君,林世德,等.核苷(酸)类似物治疗慢性乙型肝炎患者肾脏安全性研究进展[J].海南医学,2019,30(12):1587-1591.
[5] 汪亚芬,周建芳,杨珊明,等.核苷类抗病毒治疗对慢性乙型肝炎相关性肝癌患者术后预后的影响[J].上海预防医学,2017,29(10):802-805. |
| [1] |
. [J]. journal1, 2021, 41(5): 84-85. |
| [2] |
. [J]. journal1, 2021, 41(5): 105-106. |
| [3] |
. [J]. journal1, 2021, 41(2): 135-136. |
| [4] |
Wang, Jing. Changes and Significance of Serum TGF beta 1,sIL-2R and Tumor Markers Before and After Radiotherapy in Patients With Hepatocellular Carcinoma[J]. journal1, 2021, 41(1): 22-24. |
| [5] |
. [J]. journal1, 2021, 41(1): 50-50. |
| [6] |
. [J]. journal1, 2021, 41(1): 124-126. |
|
|
|
2021, Vol. 41 
